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Abstract  Functional  imaging  of  the  kidney  using  radiological  techniques  has  a  great  potential
of development  because  the  functional  parameters,  which  can  be  approached  non-invasively,
are multiple.  CT  can  provide  measurement  of  perfusion  and  glomerular  ﬁltration  but  has  the
inconvenient  to  deliver  irradiation  and  potentially  nephrotoxicity  due  to  iodine  agents  in  this
context. Sonography  is  able  to  evaluate  perfusion  only  but  quantiﬁcation  remains  problematic.
Therefore,  MR  imaging  shows  the  greatest  ﬂexibility  measuring  blood  volume  and  perfusion
as well  as  split  renal  function.  The  main  applications  of  perfusion  imaging  of  the  kidney  are
vascular diseases,  as  renal  artery  stenosis,  renal  obstruction  and  follow-up  of  renal  tumors  under
antiangiogenic  therapy.  However,  full  clinical  validation  of  these  methods  and  the  evaluation
of their  clinical  impact  are  still  often  worthwhile.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Renal  perfusion  and  glomerular  ﬁltration  rate  (GFR)  are  major  functional  parameters,
which  are  involved  in  many  parenchymal  diseases  and  used  to  monitor  the  renal  function.
Getting  an  easy,  reliable  and  reproducible  access  to  these  data,  in  conjunction  with  pre-
cise  morphological  information,  would  signiﬁcantly  improve  the  patient  care  in  nephrology.
For  example,  actually,  measurement  of  perfusion  in  clinics  is  not  reliable  and  no  reference
method  is  available  for  patients.  In  clinical  practice,  non-invasive  and  accurate  measure-
ment  of  renal  blood  ﬂow  or  perfusion  may  become  important  for  the  evaluation  of  renal
artery  stenosis  or  nephropathies  with  microvascular  involvement,  to  help  in  monitoring
intravascular  interventions,  to  characterize  renal  tumors  and  follow  them  after  antiangio-
genic  therapies.  Similarly,  GFR  is  used  as  an  index  of  functioning  renal  mass,  representing
the  sum  of  ﬁltration  rates  in  each  functioning  nephron.  Fall  of  GFR  may  be  the  earliest  and
only  clinical  sign  of  renal  disease  and  its  serial  monitoring  allows  estimating  the  severity
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nd  following  the  course  of  kidney  diseases.  If  measurement
f  GFR  with  radiological  techniques  remains  a  challenge  for
he  future,  measurement  of  the  differential  renal  function
s  now  available  for  clinical  routine.
ontrast agents and technical issues
onography
hird  generation  of  ultrasound  contrast  agents  (USCA)  are
omposed  of  microbubbles,  containing  a  gas  with  a  low
iffusibility,  stabilized  by  a  shell,  with  a  mean  diameter
ange  between  1  and  5  microns  [1]  Once  injected  into  the
lood  circulation,  these  bubbles  have  a  mono-compartment
istribution,  purely  intravascular,  without  interstitial  dif-
usion  or  glomerular  ﬁltration.  The  gas  is  eliminated  via
he  respiratory  system.  This  pharmacokinetics  character-
zes  these  agents  as  real  blood  pool  agents,  particularly
ppropriate  for  the  evaluation  of  renal  perfusion.  However,
here  are  major  constraints  making  quantiﬁcation  process
ifﬁcult  with  US:  the  response  of  both  anatomical  struc-
ures  and  microbubbles  to  an  ultrasound  beam  is  complex,
hich  requires  using  contrast-speciﬁc  imaging  modes  based
n  the  enhancement  of  the  non-linear  response  from  bub-
les;  quantiﬁcation  is  also  mainly  affected  by  shadowing
hich  results  from  inaccurate  correction  of  both  tissue  and
icrobubble  attenuation.  Variation  in  attenuation  across  the
mage  at  a  given  depth  is  not  accounted  for  by  time-gain
ompensation  (TGC).  Secondly,  there  is  no  linear  rela-
ionship  between  the  concentration  of  the  agent  and  the
ntensity  of  the  received  signal.  Third,  even  if  imaging  pro-
ocols  require  a  sonication  with  low  mechanical  indexes,  an
npredictable  part  of  microbubbles  are  destroyed  within  the
maging  plane,  in  both  the  analyzed  tissue  and  the  feed-
ng  vessels.  Some  mathematical  models  were  proposed  to
ompensate  for  this  effect  [2,3].  This  is  why  such  dynamic
tudies  require  applying  quantiﬁcation  processes  to  non-
ompressed  data,  such  as  the  true  raw  data,  which  can  be
vailable  on  certain  systems.  In  such  conditions,  the  appli-
ation  of  functional  renal  US  in  humans  has  shown  a  large
evelopment  in  semi-quantitative  evaluation  of  renal  tumor
erfusion  [4].
igure 1. Typical signal-time curve obtained in a normal kidney transp
ourtesy of Dr J.M. Correas, Necker Hospital, Paris.
r
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Renal  signal-time  curves  obtained  with  these  agents  are
haracteristic  of  non-diffusible  agents  with  only  a  vascular
eak  followed  by  recirculation  (Fig.  1).
T
odine  contrast  agents  used  for  X-rays  can  be  considered  as
lomerular  tracers  as 99mTc-DTPA  or 51Cr-EDTA  are  used  in
uclear  medicine,  they  are  freely  ﬁltered  at  the  ﬁrst  pass  by
he  glomeruli  without  any  tubular  secretion  or  reabsorption.
he  linear  relation  between  the  level  of  attenuation  and  the
ontrast  agent  concentration  is  a  great  advantage,  facilitat-
ng  modelisation.  Axial  acquisitions  with  CT  allow  including
oth  kidneys  (for  comparison)  and  aorta  to  take  into  account
he  arterial  input  function  [5,6].  There  are  several  lim-
tations  making  CT  poorly  available  for  the  quantitative
valuation  of  renal  function:  nephrotoxicity  of  iodine  agents
n  patients  with  decreased  renal  function,  the  induced  radia-
ion  dose  due  to  the  necessary  continuous  irradiation  during
cquisition  requiring  the  application  of  all  dose  reduction
ethods  and  the  impossibility  to  include  the  entire  kidney
n  the  volume  using  the  axial  transverse  plane  (4  to  6  cm
overed).
R imaging
egular  low-molecular-weight  gadolinium  (Gd)  chelates  are
till  the  only  extrinsic  agents  used  in  clinical  imaging  [7,8].
s  iodine  contrast  agents,  they  can  also  be  considered
s  glomerular  tracers.  However,  their  role  in  the  evalua-
ion  of  renal  function  shows  some  limitations:  ﬁrst,  as  the
ther  mentioned  agents,  they  are  also  freely  diffusing  into
he  interstitium,  compartment  which  is  usually  neglected
n  most  pharmacokinetic  models;  second,  the  relationship
etween  signal  intensity  (SI)  and  concentration  is  highly
omplex,  inducing  concomitant  reduction  of  T1  and  T2  (or
2*),  which  is  not  the  case  for  radioactive  agents  or  iodine
ompounds.
Concentration  of  agent  can  be  calculated  by  the  linear
elationship  to  the  R1  relaxation  rate  and  the  speciﬁc  relax-lant after injection of non-diffusible microbubbles.
vity  of  the  agent  (r):
 =  (R1  —  R10)/r
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T1-weighting:  gradient-echo  sequences  or  sequences  with
a  non-selective  magnetization  preparation  are  preferred,
combining  with  very  short  TR/TE  and  low  ﬂip  angles.
Concentration  of  Gd  within  the  kidney  can  be  very  highPerfusion  imaging  in  renal  diseases  
where  R10 is  the  bulk  R1  in  the  tissue  without  contrast  agent.
In  principle,  this  means  that  a  pre-contrast  measurement
of  R1  should  be  performed  before  injection  of  the  contrast
agent.
Measurement  of  relative  values  of  perfusion  (tumor  vs
normal  kidney  or  one  kidney  vs  the  other)  does  not  require
converting  changes  in  SI  into  changes  in  R1.  Only  absolute
values  calculation  requires  this  calculation  (mainly  for  GFR).
Measurement  of  renal  perfusion  based  on  other  types  of
contrast  agents,  such  as  larger  Gd  chelates  or  iron  oxide  par-
ticles  or  on  displacement  of  water  protons  (spin-labeling)
will  not  be  discussed  here  because  they  do  not  have  agree-
ment  for  clinics  for  the  former,  or  are  not  fully  available  for
the  latter.
With  dynamic  CT  and  MRI,  the  signal-time  curve  obtained
within  the  renal  parenchyma  with  these  diffusible  con-
trast  agents  is  characteristic  with  three  discernible  phases
(Fig.  2):  a  vascular  phase  with  a  tight  upslope  and  an  early
peak,  a  glomerulotubular  phase  with  a  slow  uptake  (the
agent  being  ﬁltered)  and  a  slowly  descending  excretory
phase.
Functional parameters
Renal ﬂow rate
Renal  blood  ﬂow  (RBF),  or  ﬂow  rate,  refers  to  the  global
amount  of  blood  reaching  the  kidney  per  unit  time  normally
expressed  in  mL/min.  This  parameter  is  usually  measured  on
a  renal  artery  or  a  renal  vein.  Measurement  of  renal  ﬂow  rate
is  based  on  the  product  of  mean  velocities  in  the  renal  artery
and  its  section  area.  The  cine  phase-contrast  MR  method  is
able  to  sample  intra-arterial  velocity  proﬁle  and  to  quantify
the  renal  blood  ﬂow  in  each  renal  vessel  without  injection
of  contrast  agent.  This  technique  is  well  described  in  the
literature  [9—11]:  it  is  based  on  the  encoding  of  phase  shifts
of  ﬂowing  spins  along  either  one  direction,  perpendicular
to  the  vessel  of  interest,  or  in  all  the  three  directions.  For
accurate  measurements  in  the  human  arteries,  the  imaging
Figure 2. Typical signal-time curve obtained in a normal kidney
transplant after injection of diffusible Gd chelate showing a vascu-
lar phase (red), a glomerulotubular phase (green) and an excretory
phase (blue).
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lane  is  usually  positioned  10  to  15  mm  downstream  from
he  ostium,  where  respiratory  movements  are  minimal,  and
erpendicularly  to  the  renal  artery  (Fig.  3).
enal perfusion
enal  perfusion  refers  to  the  blood  ﬂow  that  passes  through
 unit  mass  of  renal  tissue  (mL/min/g)  in  order  to  vascularize
t  and  exchange  with  the  extravascular  space.  The  degree  of
erfusion  depends  on  both  the  arterial  ﬂow  rate  and  local
actors,  such  as  regional  blood  volume  and  vasoreactivity.
enal  perfusion  parameters,  as  renal  blood  volume  (RBV)
nd  renal  blood  ﬂow  (RBF)  can  then  be  measured.  These
alculations  are  possible  with  dynamic  contrast-enhanced
ethods  using  CT  or  MRI.
echnical  requirements
rterial  input  function  (AIF):  in  order  to  compensate  for  the
on-instantaneous  bolus  injected  into  the  blood,  quantiﬁca-
ion  requires  an  accurate  sampling  of  the  vascular  phase  of
he  enhancement  with  a  high  temporal  resolution  to  mea-
ure  the  AIF  within  the  suprarenal  abdominal  aorta,  far  from
he  entry  volume  to  avoid  inﬂow  artifacts  (Fig.  4)  [8].  If  the
IF  is  not  taken  into  account,  only  semi-quantitative  param-
ters  as  maximal  signal  change  (MSC),  time  to  MSC  (TMSC)  or
ash-in  and  wash-out  slopes  can  be  measured  for  compari-
on  from  right  to  left  kidney,  from  cortex  to  medulla  or  from
ne  territory  to  another,  or  for  follow-up  of  the  patients
12—14].
With  MRI,  pulse-sequences  used  must  have  a  heavyigure 3. Technique of cine phase-contrast on renal arteries in a
atient with left renal artery stenosis. Acquisition planes are pos-
tioned after each ostium, perpendicular to the arterial lumen. The
elocity—time curve from the left renal artery (blue) is damped
ompared to the normal right one (red).
1316  N.  Grenier  et  al.
Figure 4. When an arterial input function (AIF) is used with MRI, the ROI has to be placed above renal arteries for native kidneys and on
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rable  to  those  derived  with  gamma  camera  scintigraphy,
using  areas  under  the  ﬁltration  curves:he lower aorta for transplanted kidneys. If positioned too high into
ue  to  water  reasbsorption  in  the  proximal  convoluted
ubule  and  in  the  medulla.  Therefore,  to  avoid  T2*  contri-
ution  to  the  signal,  the  injected  dose  must  be  lowered
etween  0.025  mmol/kg  and  0.05  mmol/kg,  and  the  patient
hould  be  well  hydrated  [15].  An  oblique-coronal  plane,
assing  through  the  long  axis  of  the  kidneys,  has  to  be
referred  to  an  axial  plane  because  with  the  later,  move-
ent  correction,  when  necessary,  is  more  difﬁcult  and  the
IF  can  be  severely  impaired  by  inﬂow  effects  within  the
orta.
With  CT,  conversion  of  densities  into  contrast  concen-
ration  is  straightforward  whereas  with  MRI,  this  conversion
s  more  hazardous.  With  the  latter,  if  conversion  is  not
ade,  only  relative  values  of  perfusion  (rRBV  and  rRBF)
an  be  extracted,  making  only  comparative  studies  possible
one  kidney/the  other;  one  area/another  area;  follow-up  of
reatments  for  tumors).
odels
alculated  concentration—time  curves  must  then  be
rocessed  using  speciﬁc  mathematical  models  (Fig.  5) [16].
ujardin  et  al.  [17,18]  generalized  the  tracer  kinetic  theory
rom  intravascular  to  diffusible  tracers  using  deconvolution,
hich  is  a  model-free  approach.  From  ROI  drawn  on  the
orta  and  on  the  renal  cortex,  tissue  concentration—time
ourse  has  to  be  deconvolved  pixel  by  pixel  with  the
ow  corrected  aortic  time  course,  resulting  in  an  impulse
esponse  function  (IRF).  This  method  allows  getting  intra-
enal  maps  of  RBF,  as  maximum  of  IRF,  RBV,  as  the  time
ntegral  of  the  IRF  over  the  available  time  interval,  and
TT  as  the  ratio  RVD/RBF.  Others  used  a  two-compartment
odel,  giving  access  to  RBV,  RBF  and  additional  parame-
ers,  such  as  GFR,  for  renal  diseases  (see  below)  or  tissue
ermeability,  for  tumors.ost-processing  methods
hen  only  perfusion  is  required,  dynamic  CT  or  MR  acquisi-
ions  can  be  short  in  time,  compatible  with  a  single  breathvolume, it can be hampered by inﬂow artifacts.
old,  because  one  needs  only  the  ﬁrst  renal  pass.  However,
hen  complementary  parameters  are  necessary,  as  perme-
bility  or  GFR  measurements,  movement  correction  must
e  applied  because  they  require  longer  acquisition  times.
everal  methods  have  been  proposed  [19]  but  not  always
vailable  commercially  (Fig.  6).
easurement of split renal function
emi-quantitative  evaluation  of  renal  function,  as  split  (or
ifferential)  renal  function  is  sufﬁcient  in  urological  man-
gement  of  most  uropathies,  mainly  obstructive.  However,
t  is  usually  not  useful  in  daily  assessment  and  follow-up  of
enal  diseases.  In  the  nephrologic  ﬁeld,  it  can  be  required
hen  a  reduced  renal  function  is  associated  with  renal  asym-
etry,  in  renovascular  diseases,  before  renal  surgery,  if
enal  function  is  altered  or  before  renal  biopsy.  The  split
enal  function  (given  in  percentage)  corresponds,  for  each
idney,  to  the  product:
F  (%)  =  RF/RFtotal ×  100
where  RFtotal is  the  sum  of  RFs  of  both  kidneys.
In  clinical  routine,  the  split  renal  function  is  still  mea-
ured  using  nuclear  medicine  with  glomerular  (99mTc-DTPA)
r  tubular  (99mTc-MAG3)  agents.  Two  methods  are  promoted
or  that  purpose:  either  the  calculation  of  areas  under  the
ltration  curves  or  Rutland—Patlak  plots:
using  dynamic  contrast-enhanced  MR  imaging,
Rohrschneider  et  al.  [20]  obtained  calculations  of
the  percentage  of  the  single-kidney  ‘‘activity’’  compa-RF  =  AUC  (mm2) ×  S  (mm2)
where  AUC  corresponds  to  the  area  under  the  glomerulo-
tubular  segment  of  the  time—intensity  curve  and  S  is  the
ROI  area  (Fig.  7).
Perfusion  imaging  in  renal  diseases  1317
Figure 5. Two-compartments model. From the cortical signal intensity—time curve and from the AIF, a two-compartment model can be
applied on voxel-by-voxel basis. We can obtain maps of perfusion (in mL/g/min) and vascular volume (in %).
Figure 6. Impact of movement correction on functional maps:
corrected maps (above) versus non-corrected maps (bottom)
Measurement of GFR
Whereas  the  level  of  GFR  is  the  best  index  for  monitoring
chronic  kidney  diseases  (CKD),  measurement  of  glomerular
ﬁltration  is  difﬁcult  to  obtain  accurately  in  routine.  Esti-
mated  renal  clearance  has  several  limitations  [22]:
• variations  of  plasma  creatinine  level  are  around  10%;
• some  tubular  secretion  may  lead  to  the  overestimation  of
GFR,  particularly  in  advanced  renal  failure;
• there  is  a  reduction  of  creatinine  excretion  with  age-
related  to  a  decrease  in  skeletal  muscle  mass;Reprinted with permission from Denis-de-Senneville et al., JMRI
2008;28:970—8.
• the  Rutland—Patlak  plot  technique  is  a  graphical  method
based  on  a  two-compartmental  model  with  the  assump-
tions  that  the  rate  of  change  of  concentration  in  the
kidney  during  the  clearance  phase  is  constant  if  the
amount  of  contrast  agent  is  taken  into  account  during
this  period  [21].  The  assumption  that  no  contrast  agent
leaves  the  ROI  during  the  sampling  period  may  justify
theoretically  the  use  of  ROIs  encompassing  both  cortex
and  medulla.  The  model  is  realized  as  a  x—y  plot  using
the  ratio  of  the  renal  concentration/aortic  concentration
plotted  against  the  ratio  of  the  integral  of  aortic  concen-
tration/aortic  concentration.  When  applied  to  the  second
phase  of  the  signal  intensity—time  curve  (glomerulotubu-
lar  uptake),  this  plot  leads  to  a  straight  line,  with  a  slope
proportional  to  the  renal  clearance,  and  an  intercept
with  the  y-axis  proportional  to  the  cortical  blood  volume
(Fig.  8).
Figure 7. Measurement of the differential renal function, in a
patient with a left hydronephrosis, using the method of areas under
the glomerulotubular phase.
1318  N.  Grenier  et  al.
Figure 8. Principle of the Patlak—Rutland method. Based on the AIF and on the signal intensity—time curve from the renal cortex, the time
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foints corresponding to the glomerulotubular phase are selected. T
o ﬁltration and the intersection with vertical axis corresponds to b
ﬁnally,  in  acute  or  rapidly  progressing  renal  failure,  this
technique  provides  inaccurate  information  when  GFR  is
rapidly  changing.
Measuring  GFR  with  dynamic  CT  or  MRI  still  requires  eval-
ation  and  validation  phases  before  translated  in  routine
ractice.
linical applications
he  main  clinical  applications  of  perfusion  measurements
re  renal  vascular  diseases.  In  assessment  of  renal  tumors,
oth  perfusion  and  extravascular  leak  are  considered.  The
ain  clinical  application  of  split  renal  function  is  chronic
rinary  obstruction.
enal artery stenosis (RAS)
iagnosis  of  RAS  is  now  based  on  non-invasive  techniques
s  Doppler  sonography,  CT-  or  MR-angiography.  Consider-
ng  grading  the  severity  of  narrowing,  the  reproducibility
f  this  evaluation  is  not  perfect,  explaining  some  discrep-
ncies  in  published  results,  and  it  is  not  a  good  predictor
f  functional  improvement  after  revascularization.  Several
unctional  tests  have  been  proposed  in  the  past  to  char-
cterize  ‘‘functional  stenoses’’  as  captopril-scintigraphy  or
aptopril-MRI.  These  approaches  are  not  used  routinely  any-
ore.  Therefore,  measurement  of  renal  blood  ﬂow  or  renal
erfusion,  added  to  the  morphologic  evaluation  in  the  same
xamination,  can  assess  the  haemodynamic  signiﬁcance  of
tenoses.  Schoenberg  et  al.  [23]  used  ﬁrst  cardiac-gated
hase-contrast  ﬂow  measurement  to  complete  morpholog-
cal  acquisitions.  Agreement  between  the  morphological
egree  of  stenosis  and  changes  in  the  pattern  of  the  ﬂow
roﬁle  was  ﬁrst  documented  in  animal  and  then,  in  human
tudies  [10,11,24].  The  loss  of  the  early  systolic  peak  was
roposed  as  a  sensitive  indicator  for  the  loss  of  the  autoreg-
latory  capacity  and  the  onset  of  signiﬁcant  mean  ﬂow
eduction.  This  ﬂow  measurement  technique  provided  a
unctional  grading  of  the  degree  of  stenosis  independent
f  the  morphologic  grading  (Fig.  9).  These  observations
ere  conﬁrmed  by  a  multicenter  trial,  showing  a  signiﬁcant
eduction  in  interobserver  variability  and  an  improvement
o
b
l
btlak plot shows a good alignment of points. The slope corresponds
 volume (%).
f  overall  accuracy  compared  with  DSA,  with  sensitivities
nd  speciﬁcities  exceeding  95%.
Evaluation  of  perfusion  also  provided  quantiﬁed  func-
ional  information  in  these  patients  (Fig.  10) [24].  Michaely
t  al.  [14],  ﬁrst  calculated  semi-quantitative  parameters,
uch  as  mean  transit  time  (MTT),  maximal  upslope  (MUS)  of
he  curve,  maximum  SI,  and  time  to  SI  peak  (TTP)  after  a
amma  variate  ﬁt  of  the  signal  intensity—time  curve.  Sig-
iﬁcant  differences  between  patients  without  stenoses  or
ith  low-to-intermediate  grade  stenoses  and  patients  with
igh-grade  stenoses  were  found  for  each  of  these  parame-
ers  (Fig.  10).  Based  on  a small  series  of  27  patients,  the
ame  group  evaluated  the  diagnostic  accuracy  of  quantiﬁed
enal  perfusion  in  identifying  and  differentiating  renovascu-
ar  from  renal  parenchymal  disease  [16]. Measurement  of
R  perfusion  yielded  a  sensitivity  of  100%  and  a  speciﬁcity
f  85%  utilizing  an  optimal  plasma  ﬂow  threshold  value  of
50  mL/100  mL/min,  whereas  single  MRA  achieved  a  sen-
itivity  of  51.9%  and  a  speciﬁcity  of  90%.  An  example  of
uantiﬁcation  of  renal  perfusion  in  a case  of  left  RAS  is
hown  in  Fig.  11.
Follow-up  of  RAS  after  revascularisation  is  another  appli-
ation  of  these  quantitative  functional  studies,  adding
bjective  hemodynamic  criteria  to  the  morphologic  analysis
f  the  artery  [7].
enal obstruction
echnically,  the  acquisition  mode  is  the  same  than  for  per-
usion  studies.  However,  injection  of  furosemide  is  now
ecommended  just  before  the  injection  of  Gd,  at  a  dose  of
 mg/kg  in  neonates  and  0.5  mg/kg  in  infants  and  adults.  For
he  split  renal  function,  comparison  between  both  kidneys
ased  on  the  Rutland—Patlak  plot  is  preferred  to  measure-
ent  of  areas  under  the  curves  (see  above)  (Fig.  12).  A
rospective  multicentric  study  in  France  on  295  patients  [25]
howed  that  both  techniques  are  equivalent  for  cases  with
ild  to  moderate  pyelectasis  but  underestimated  the  values
or  highly  dilated  kidneys.
Grading  obstruction  by  placing  an  additional  region-f-interest  on  the  pyelocaliceal  system  is  more  difﬁcult
ecause  many  factors  of  variability  may  occur,  such  as  the
evel  of  split  function,  the  volume  of  cavities,  the  degree  of
ladder  ﬁlling. .  .
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Figure 9. Cine phase-contrast ﬂow curves for different degrees of renal artery stenosis. A. Normal ﬂow proﬁles reveal a characteristic
early systolic peak and a midsystolic maximum. B. Low-grade stenoses typically reveal only a partial loss of the early systolic peak (solid
arrow). C. Moderate stenoses demonstrate an almost complete loss of the early systolic peak and a decrease of the midsystolic maximum
ow p
l 200
v
d
a
a
[
[(open arrow). D. High-grade stenoses have a featureless ﬂattened ﬂ
Reprinted with permission from Schoenberg et al., J Am Soc Nephro
Follow-up of renal tumors under
antiangiogenic treatment
This  application  has  emerged  with  the  development  of  new
targeted  therapies  as  antiangiogenic  drugs.  Renal  cancer  is
a  major  target  for  these  treatments.  The  largest  experi-
ence  in  that  ﬁeld  was  conducted  with  USCAs.  Lassau  et  al.
[26]  deﬁned  the  different  pertinent  parameters  for  such
applications,  such  as  the  TTP,  the  AUC  during  the  wash-in
or  the  AUC  during  the  wash-out  with  a  low  interoperator
b
e
oroﬁle.
2;13:158—69.
ariability.  They  showed  that  this  method  was  able  to
emonstrate  the  effect  of  antiangiogenic  treatment  as  early
s  day  15  in  metastatic  renal  cancer  or  day  3  for  hep-
tocarcinomas,  differentiating  good  and  bad  responders
27,28].
The  same  approach  was  validated  with  dynamic  CT
29]  providing  discriminant  quantiﬁed  values  of  BF  and  BV
etween  responders  and  non-responders  after  one  cycle.  An
xample  of  good  response  of  a renal  tumor  after  three  cycles
f  antiangiogenic  therapy  is  shown  in  Fig.  13.
1320  N.  Grenier  et  al.
Figure 10. Semi-quantitative measurement of perfusion using mean transit time (MTT) in patients without (0) and with mild (1) or severe
(2) renal artery stenosis.
Reprinted with permission from Michaely H.J. et al., Radiology 2006;238:586—96.
Figure 11. Quantiﬁcation of renal perfusion in a patient with left renal artery stenosis. Signal intensity—time curves show the asymmetry.
By applying a two-compartment model and taking into account the AIF, perfusion maps can be obtained, which demonstrate the asymmetry
of vascularisation.
Figure 12. Patlak plots obtained in a child with left urinary obstruction. The anatomic image shows dilatation of the left pyelocaliceal
system. The left plot (red) shows a lower slope corresponding to a lower ﬁltration rate than the right (green). (Courtesy of M. Claudon,
Nancy, France).
Perfusion  imaging  in  renal  diseases  
Figure 13. Perfusion maps in a patient with a metastatic renal
tumor of the right lower pole, imaged before and after three cycles
D
T
c
Rof antiangiogenic therapy. Functional maps show a decrease of per-
fusion values induced by treatment.
Conclusion
Evaluation  of  perfusion  in  kidney  diseases  is  increasing
in  clinical  routine.  MR  imaging  provides  more  ﬂexibility
for  measurement  of  blood  ﬂow,  perfusion  and  split  renal
function  without  being  nephrotoxic.  CEUS  and  dynamic
CT  are  probably  more  appropriate  for  evaluating  response
to  antiangiogenic  treatments.  However,  adapted  post-
processing  software  have  still  to  be  implemented  on  our  MR
systems  to  increase  the  diffusion  of  these  techniques.
TAKE-HOME  MESSAGES
General  assessments
• Renal  perfusion  can  be  assessed  semi-quantitatively
and  quantitatively.
• Quantitative  measurements  make  inter-patient
comparative  studies  more  accurate.
• DCE-US  allows  semi-quantitative  measurements  only.
• DCE-CT  and  DCE-MRI  allow  both,  semi-quantitative
and  quantitative  measurements.
• DCE-CT  and  DCE-MRI  allow  measurement  of  both,
perfusion  and  differential  renal  function.
Technical  points
• Measurement  of  semi-quantitative  parameters
requires  only  SI  changes  within  the  kidney.
• Measurement  of  quantitative  parameters  requires
also  SI  changes  within  abdominal  aorta  (AIF).• DCE-US  requires  having  access  to  raw  data  or
linearized  post-processed  data.1321
• Movement  correction  by  post-processing  is  required
due  to  renal  respiratory  movements.
• In  DCE-MRI,  only  a  small  dose  of  Gd  (0.05  mL/kg)  is
required  to  avoid  T2*  effects  within  kidney.
• Rutland—Patlak  plot  is  preferred  for  measurement  of
differential  renal  function.
Main  results
• Measurement  of  renal  blood  ﬂow  improves  the
interobserver  variability  for  diagnosis  of  signiﬁcant
RAS.
• A  renal  perfusion  value  <  150  Ml/min  has  a  sensitivity
of  100%  for  diagnosis  of  signiﬁcant  RAS.
• Functional  studies  provide  unequivocal  data  on  renal
perfusion  after  revascularization.
• Measurement  of  differential  renal  function  with
scintigraphy  and  DCE-MRI  provides  equivalent  results
in  renal  obstruction.
• Response  to  antiangiogenic  therapy  can  be  evaluated
early  by  perfusion  studies  in  metastatic  renal  cell
carcinoma.
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